Our research revealed that knockdown of XIST significantly reduced expression levels of tumor-related genes (Wnt1, β-catenin and cyclin-D1) in the Wnt/β-catenin signaling pathway in bladder cancer cells. The gene discussed is CCND1; the disease is urinary bladder carcinoma.